Factors associated with progression to CIN 2 + were presence of HPV-18 ( relative risk = 3.04 ; 95 % CI = 1.09-8 .44 ) and HPV-16 and/or HPV-18 at recruitment ( relative risk = 3.98 ; 95 % CI = 1.60-9 .90 ) .